
ABBV
AbbVie Inc.
$222.59
+$0.12(+0.05%)
75
Overall
60
Value
90
Tech
--
Quality
Market Cap
$393.01B
Volume
5.91M
52W Range
$163.81 - $223.49
Target Price
$226.08
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $22.9B | $25.6B | $28.2B | $32.8B | $33.3B | $45.8B | $56.2B | $58.1B | $54.3B | $56.3B | ||
Total Revenue | $22.9B | $25.6B | $28.2B | $32.8B | $33.3B | $45.8B | $56.2B | $58.1B | $54.3B | $56.3B | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $4.5B | $5.8B | $7.0B | $7.7B | $7.4B | $15.4B | $17.4B | $17.4B | $20.4B | $16.9B | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $18.4B | $19.8B | $21.2B | $25.0B | $25.8B | $30.4B | $38.8B | $40.6B | $33.9B | $39.4B | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $10.8B | $10.4B | $11.6B | $18.7B | $12.8B | $19.1B | $20.8B | $21.8B | $21.1B | $30.3B | ||
Research & Development | $4.4B | $4.6B | $5.3B | $10.8B | $6.8B | $7.8B | $8.0B | $7.2B | $8.5B | $15.6B | ||
Research Expense | $4.3B | $4.4B | $5.0B | $10.3B | $6.4B | $6.6B | $6.9B | $6.5B | $7.7B | $12.8B | ||
Selling, General & Administrative | $6.4B | $5.9B | $6.3B | $7.4B | $6.9B | $11.3B | $12.3B | $15.3B | $12.9B | $14.8B | ||
Selling & Marketing Expenses | $704.0M | $764.0M | $846.0M | $1.1B | $1.1B | $1.8B | $2.1B | $2.0B | $2.2B | $2.1B | ||
General & Administrative Expenses | $6.4B | $5.9B | $6.3B | $7.4B | $6.9B | $11.3B | $12.3B | $15.3B | $12.9B | $14.8B | ||
Promotion & Advertising | $704.0M | $764.0M | $846.0M | $1.1B | $1.1B | $1.8B | $2.1B | -- | -- | -- | ||
Salaries & Wages | $-89.0M | $-104.0M | $-73.0M | $-73.0M | $-80.0M | $-131.0M | $-126.0M | -- | -- | -- | ||
Depreciation & Amortization | $417.0M | $425.0M | $425.0M | $471.0M | $464.0M | $666.0M | $803.0M | $778.0M | $752.0M | $764.0M | ||
Depreciation & Amortization | $417.0M | $425.0M | $425.0M | $471.0M | $464.0M | $666.0M | $803.0M | -- | -- | -- | ||
Amortization | $19.7B | $28.9B | $27.6B | $21.2B | $18.6B | $82.9B | $76.0B | $67.4B | $55.6B | $60.1B | ||
Other Operating Expenses | $-187.0M | $-118.0M | $-1.8B | $500.0M | $-890.0M | $-91.0M | $432.0M | $56.0M | $-179.0M | $-7.0M | ||
OPERATING INCOME | ||||||||||||
Operating income | $7.5B | $9.4B | $9.5B | $6.4B | $13.0B | $11.4B | $17.9B | $18.1B | $12.8B | $9.1B | ||
EBITDA | $8.2B | $10.1B | $10.4B | $8.3B | $12.3B | $12.3B | $23.9B | $24.2B | $17.1B | $14.9B | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $719.0M | $1.0B | $1.1B | $1.3B | $1.8B | $2.5B | $2.4B | $2.2B | $2.2B | $2.8B | ||
Intinc | $-686.0M | $-965.0M | $-1.0B | $-1.1B | $-1.5B | $-2.3B | $-2.4B | $-2.0B | $-1.7B | $-2.2B | ||
Net Non-Operating Interest Income/Expense | $-686.0M | $-965.0M | $-1.0B | $-1.1B | $-1.5B | $-2.3B | $-2.4B | $-2.0B | $-1.7B | $-2.2B | ||
Gain on Sale of Securities | $218.0M | $-252.0M | $90.0M | -- | -- | -- | -- | -- | -- | -- | ||
Other Income/Expense | $13.0M | $232.0M | $466.0M | $18.0M | $3.0B | $5.6B | $2.5B | $-3.3B | $4.7B | $3.2B | ||
Other Special Charges | $-13.0M | $-232.0M | $-466.0M | $-18.0M | $-3.0B | $-5.6B | $-2.5B | $-2.4B | $-4.7B | $-3.2B | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | $126.0M | $52.0M | $86.0M | $59.0M | $219.0M | -- | -- | -- | -- | -- | ||
Special Income Charges | $-126.0M | $-52.0M | $-440.0M | $-59.0M | $-219.0M | -- | -- | -- | $2.9B | $4.6B | ||
Impairment of Capital Assets | -- | -- | $354.0M | -- | -- | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $7.4B | $8.9B | $8.9B | $6.5B | $10.2B | $5.9B | $15.4B | $15.7B | $8.5B | $6.5B | ||
Pre-Tax Income | $6.6B | $7.9B | $7.7B | $5.2B | $8.4B | $3.4B | $13.0B | $13.5B | $6.3B | $3.7B | ||
INCOME TAX | ||||||||||||
Tax Provision | $1.5B | $1.9B | $2.4B | $-490.0M | $544.0M | $-1.2B | $1.4B | $1.6B | $1.4B | $-570.0M | ||
NET INCOME | ||||||||||||
Net Income | $5.1B | $6.0B | $5.3B | $5.7B | $7.9B | $4.6B | $11.5B | $11.8B | $4.9B | $4.3B | ||
Net Income (Continuing Operations) | $5.1B | $6.0B | $5.3B | $5.7B | $7.9B | $4.6B | $11.5B | $11.8B | $4.9B | $4.3B | ||
Net Income (Discontinued Operations) | $5.1B | $6.0B | $5.3B | $5.7B | $7.9B | $4.6B | $11.5B | $11.8B | $4.9B | $4.3B | ||
Net Income (Common Stockholders) | $5.1B | $6.0B | $5.3B | $5.7B | $7.9B | $4.6B | $11.5B | $11.8B | $4.9B | $4.3B | ||
Normalized Income | $4.4B | $5.4B | $6.1B | $4.8B | $9.7B | $2.2B | -- | -- | -- | -- | ||
TOTALS | ||||||||||||
Total Expenses | $15.3B | $16.3B | $18.7B | $26.4B | $20.3B | $34.4B | $38.2B | $39.2B | $41.6B | $47.2B | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B | $1.7B | $1.8B | $1.8B | $1.8B | $1.8B | ||
Average Shares Outstanding (Diluted) | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B | $1.7B | $1.8B | $1.8B | $1.8B | $1.8B | ||
Shares Outstanding | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | ||
Basic EPS | $3.15 | $3.65 | $3.31 | $3.67 | $5.3 | $2.73 | $6.48 | $6.65 | $2.73 | $2.4 | ||
Basic EPS (Continuing Operations) | $3.15 | $3.65 | $3.31 | $3.67 | $5.3 | $2.73 | $6.48 | $6.65 | $2.73 | $2.4 | ||
Diluted EPS | $3.13 | $3.63 | $3.3 | $3.66 | $5.28 | $2.72 | $6.45 | $6.63 | $2.72 | $2.39 | ||
Diluted EPS (Continuing Operations) | $3.13 | $3.63 | $3.3 | $3.66 | $5.28 | $2.72 | $6.45 | $6.63 | $2.72 | $2.39 | ||
Dividend Per Share | $2.1 | $2.35 | $2.63 | -- | $4.39 | $4.84 | $5.31 | $5.71 | $5.99 | $6.29 | ||
OTHER METRICS | ||||||||||||
Development Expense | $150.0M | $200.0M | $327.0M | $424.0M | $385.0M | $1.2B | $1.1B | $697.0M | $778.0M | $2.8B | ||
Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | $68.0M | -- | -- | -- | ||
Minority Interests | -- | -- | -- | -- | $-8.2B | $-6.0M | $-7.0M | $-9.0M | $-10.0M | $-8.0M | ||
Other Gand A | $6.4B | $5.9B | $6.3B | $7.4B | $6.9B | $11.3B | $12.3B | $15.3B | $12.9B | $14.8B | ||
Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $50.0M | -- | -- | -- | ||
Rent And Landing Fees | $146.0M | $159.0M | $169.0M | $161.0M | -- | -- | -- | -- | -- | -- | ||
Restruct | $126.0M | $52.0M | $86.0M | $59.0M | $219.0M | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ABBV | $222.59 | +0.1% | 5.91M |
3 | ||||
4 | ||||
5 | ||||
6 |